Wakabayashi M
Department of Transplantation I, Tokai University School of Medicine.
Nihon Hinyokika Gakkai Zasshi. 1998 Sep;89(9):749-57. doi: 10.5980/jpnjurol1989.89.749.
Diethylenetriamine penta acetic acid (99mTc-DTPA), a substance which indicates glomerular filtration, is distributed equally in blood and tissue after a bolus intravenously injection. Ambulatory Renal Monitor (ARM) is a portable and non invasive device which monitors extracorporeally the clearance of intravenously injected 99mTc-DTPA. We examined correlation between half-time of clearance estimated by ARM and glomerular filtration rare, and clinical usefulness of ARM for a renal function monitoring.
The purposes of this paper are to describe the results obtained through basic analysis experiments and reproducibility in normal control, and its clinical application for 9 renal transplant patients, three drug-induced renal damage, one acute renal failure, one hemolytic uremic syndrome (HUS), two chronic nephritis, one donor of renal transplantation, one ureteral tumor, three renal tumors, two ureteral stones, one bilateral hydronephrosis and two normal controls. The half time of clearance of the tracer measured by an ARM. (ARM-HTC) is compared with the half time of clearance of the tracer measured by repeated blood sampling (Sampling-HTC) as a golden standard, serum creatinine and creatinine clearance.
A significant correlation (linear) was detected when ARM-HTC was compared with Sampling-HTC (r = 0.91), 1/serum creatinine (r = 0.85) or creatinine clearance (r = 0.82), although ARM-HTC showed a delay compared with Sampling-HTC.
The reason of this delay may be due to a difference in half-time when the tracer distributed in the blood and tissue. The results indicate that the estimation of 99mTc-DTPA clearance by ARM is valuable for renal function evaluation in wide ranges of renal function and in different origins of renal dysfunction such as in renal transplantation.
二乙烯三胺五乙酸(99mTc - DTPA)是一种可指示肾小球滤过的物质,静脉推注后在血液和组织中均匀分布。动态肾监测仪(ARM)是一种便携式无创设备,可体外监测静脉注射99mTc - DTPA的清除率。我们研究了ARM估算的清除半衰期与肾小球滤过率之间的相关性,以及ARM在肾功能监测中的临床应用价值。
本文旨在描述通过基础分析实验获得的结果、在正常对照中的可重复性,以及其在9例肾移植患者、3例药物性肾损伤患者、1例急性肾衰竭患者、1例溶血尿毒综合征(HUS)患者、2例慢性肾炎患者、1例肾移植供体、1例输尿管肿瘤患者、3例肾肿瘤患者、2例输尿管结石患者、1例双侧肾积水患者和2例正常对照中的临床应用情况。通过ARM测量示踪剂的清除半衰期(ARM - HTC),并与作为金标准的重复采血测量的示踪剂清除半衰期(采样 - HTC)、血清肌酐和肌酐清除率进行比较。
当ARM - HTC与采样 - HTC(r = 0.91)、1/血清肌酐(r = 0.85)或肌酐清除率(r = 0.82)进行比较时,检测到显著的相关性(线性关系),尽管ARM - HTC与采样 - HTC相比存在延迟。
这种延迟的原因可能是示踪剂在血液和组织中分布的半衰期存在差异。结果表明,通过ARM估算99mTc - DTPA清除率对于在广泛的肾功能范围以及不同肾功能障碍病因(如肾移植)中评估肾功能具有重要价值。